These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37387824)

  • 1. Retracted: Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9867613. PubMed ID: 37387824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude.
    Chang R; Wu J; Zhang X; Ye Y; Zhou W; Liu Y
    Evid Based Complement Alternat Med; 2021; 2021():2849982. PubMed ID: 34754313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of high platelet reactivity in Chinese patients with coronary heart disease under clopidogrel therapy.
    Zou X; Deng XL; Wang YM; Li JH; Liu L; Huang X; Liu L; Cao J; Fan L
    Int J Clin Pharm; 2020 Feb; 42(1):158-166. PubMed ID: 32253660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention.
    Yao Y; Tang XF; Zhang JH; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Chen J; Wang M; Xu B; Gao RL; Yuan JQ
    Thromb Res; 2016 May; 141():28-34. PubMed ID: 26962983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial).
    Pettersen AÅ; Seljeflot I; Abdelnoor M; Arnesen H
    J Am Heart Assoc; 2012 Jun; 1(3):e000703. PubMed ID: 23130135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation.
    Markers D
    Dis Markers; 2023; 2023():9845626. PubMed ID: 37387757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
    Hokimoto S; Chitose T; Mizobe M; Akasaka T; Arima Y; Kaikita K; Iwashita S; Morita K; Miyazaki H; Oniki K; Matsui K; Nakagawa K; Ogawa H
    Eur J Clin Pharmacol; 2014 Jun; 70(6):667-73. PubMed ID: 24763934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: To Analyze the Influencing Factors of Senile Coronary Heart Disease Patients Complicated with Frailty Syndrome.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9785980. PubMed ID: 37799665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrel.
    Thomas MR; Wijeyeratne YD; May JA; Johnson A; Heptinstall S; Fox SC
    Platelets; 2014; 25(8):612-8. PubMed ID: 24433232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".
    Motovska Z; Widimsky P; Petr R; Bilkova D; Marinov I; Simek S; Kala P;
    J Cardiovasc Pharmacol; 2009 May; 53(5):368-72. PubMed ID: 19247187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
    Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
    Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
    Gaspoz JM; Coxson PG; Goldman PA; Williams LW; Kuntz KM; Hunink MG; Goldman L
    N Engl J Med; 2002 Jun; 346(23):1800-6. PubMed ID: 12050341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
    Breet NJ; van Werkum JW; Bouman HJ; Kelder JC; Harmsze AM; Hackeng CM; ten Berg JM
    Heart; 2011 Jun; 97(12):983-90. PubMed ID: 21478385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Analysis of Inducing Factors of Chronic Pulmonary Heart Disease Caused by Chronic Obstructive Pulmonary Disease at High Altitude through Epidemiological Investigation under Intelligent Medicine and Big Data.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9829637. PubMed ID: 37829385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
    Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study.
    Shi QP; Luo XY; Zhang B; Wang XG; Zhao J; Xie QF; Liu JH; Liu YK; Jiang J; Zheng B
    Front Pharmacol; 2022; 13():950719. PubMed ID: 36052139
    [No Abstract]   [Full Text] [Related]  

  • 19. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
    Siasos G; Oikonomou E; Zaromitidou M; Kioufis S; Kokkou E; Mourouzis K; Vlasis K; Vavuranakis M; Stone PH; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Sep; 242(1):102-8. PubMed ID: 26188531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.